Chocolate and prevention of cardiovascular disease: A systematic review

被引:180
|
作者
Ding, Eric L. [1 ]
Hutfless, Susan M.
Ding, Xin
Girotra, Saket
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA
[3] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA
关键词
D O I
10.1186/1743-7075-3-2
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Consumption of chocolate has been often hypothesized to reduce the risk of cardiovascular disease (CVD) due to chocolate's high levels of stearic acid and antioxidant flavonoids. However, debate still lingers regarding the true long term beneficial cardiovascular effects of chocolate overall. Methods: We reviewed English-language MEDLINE publications from 1966 through January 2005 for experimental, observational, and clinical studies of relations between cocoa, cacao, chocolate, stearic acid, flavonoids ( including flavonols, flavanols, catechins, epicatechins, and procynadins) and the risk of cardiovascular disease ( coronary heart disease (CHD), stroke). A total of 136 publications were selected based on relevance, and quality of design and methods. An updated meta-analysis of flavonoid intake and CHD mortality was also conducted. Results: The body of short-term randomized feeding trials suggests cocoa and chocolate may exert beneficial effects on cardiovascular risk via effects on lowering blood pressure, anti-inflammation, anti-platelet function, higher HDL, decreased LDL oxidation. Additionally, a large body of trials of stearic acid suggests it is indeed cholesterol-neutral. However, epidemiologic studies of serum and dietary stearic acid are inconclusive due to many methodologic limitations. Meanwhile, the large body of prospective studies of flavonoids suggests the flavonoid content of chocolate may reduce risk of cardiovascular mortality. Our updated meta-analysis indicates that intake of flavonoids may lower risk of CHD mortality, RR = 0.81 (95% CI: 0.71 - 0.92) comparing highest and lowest tertiles. Conclusion: Multiple lines of evidence from laboratory experiments and randomized trials suggest stearic acid may be neutral, while flavonoids are likely protective against CHD mortality. The highest priority now is to conduct larger randomized trials to definitively investigate the impact of chocolate consumption on long-term cardiovascular outcomes.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] The Role of Niacin in Cardiovascular Disease Prevention: A Systematic Review and Meta-analysis
    D'Andrea, Elvira
    Hey, S.
    Ramirez, C. L.
    Kesselheim, A.
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2019, 29 : 139 - 139
  • [22] Polypills for Primary Prevention of Cardiovascular Disease: A Systematic Review and Meta-Analysis
    Kandil, Omneya A.
    Motawea, Karam R.
    Aboelenein, Merna M.
    Shah, Jaffer
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [23] Walking for prevention of cardiovascular disease in men and women: a systematic review of observational studies
    Boone-Heinonen, J.
    Evenson, K. R.
    Taber, D. R.
    Gordon-Larsen, P.
    [J]. OBESITY REVIEWS, 2009, 10 (02) : 204 - 217
  • [24] A Systematic Review of Best Practices for Cardiovascular Disease Prevention in Persons with Rheumatoid Arthritis
    Barber, Claire
    Smith, Alexa
    Esdaile, John
    Barnabe, Cheryl
    Martin, Liam
    Faris, Peter
    Noormohamed, Raheem
    Alvarez, Nanette
    Mancini, John
    Lacaille, Diane
    Keeling, Stephanie
    Avina-Zubieta, Antonio
    Marshall, Deborah
    [J]. JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1446 - 1447
  • [25] "Mediterranean" Dietary Pattern for the Primary Prevention of Cardiovascular Disease: A Cochrane Systematic Review
    Rees, Karen
    Flowers, Nadine
    Hartley, Louise
    Clarke, Aileen
    Thorogood, Margaret
    Stranges, Saverio
    [J]. CIRCULATION, 2013, 127 (12)
  • [26] Colchicine for Secondary Cardiovascular Prevention: A Systematic Review
    Webb, Carly A.
    Barry, Arden R.
    [J]. PHARMACOTHERAPY, 2020, 40 (06): : 575 - 583
  • [27] Cocoa, Chocolate, and Cardiovascular Disease
    Galleano, Monica
    Oteiza, Patricia I.
    Fraga, Cesar G.
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2009, 54 (06) : 483 - 490
  • [28] Prevention of cardiovascular disease - A literature review
    Papoz, L
    [J]. ANNALES D ENDOCRINOLOGIE, 2001, 62 (04) : 274 - 279
  • [29] SYSTEMATIC REVIEW OF CLINICAL PRACTICE GUIDELINES FOR USE OF ASPIRIN IN PRIMARY CARDIOVASCULAR DISEASE PREVENTION
    Chatrath, N.
    Klavans, M.
    Singletary, G.
    Bhatia, J.
    Bazzano, L.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (02) : 584 - 584
  • [30] Systematic review of clinical guidelines for lipid lowering in the secondary prevention of cardiovascular disease events
    Brown, Rosemary Elisabeth
    Welsh, Paul
    Logue, Jennifer
    [J]. OPEN HEART, 2020, 7 (02):